This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is an early-stage clinical trial to determine a safe and effective dose for Tivoxavir Marboxil (TRX-100) in patients with mild to moderate Influenza. Participants will take a study drug as well as a standard therapy. A descriptive statistics will be used to present the study results.
Epistemonikos ID: 29a57dd4f467f6d1eb125702726101e3cb2ddde6
First added on: Jan 29, 2026